VIEW ONLINE  
 
 
 
 
 
23 December 2019
 
 
 
Hello Voornaam,
 

Prosus appears unlikely to succeed in its bid to buy Just Eat as it grows its food delivery platform. The UK group has again urged its shareholders to disregard an improved offer from the Naspers spinoff and rather to support a merger with rival Takeaway.com. Neither group will increase offers they revised last week. And with close to half of Just Eat's shareholders already siding with Takeaway.com, it is likely to emerge the victor on 10 January when it comes down to the vote. Share in Prosus and parent Naspers both rose on Friday, perhaps a sign that shareholders are relieved that it won't end up overpaying for a business that will require further investment.

Meanwhile, Ascendis Health's shares continued their steep descent despite the pharmaceuticals group reporting strong growth from Remedica after failing to sell the Cyprus-based business. Stock exchange operator JSE Limited also fell after it warned a weaker earnings this year after a decline in first-half trading activity and a number of once-off payments, including recent management changes.

More on those stories to follow along with news of a possible land acquisition in DRC for Glencore's Katanga subsidiary and PSG's disposal of its stake in radio frequency technology holding group Alaris.

Finally, if you're still looking for a stocking filler with the potential for investment returns beyond the festive season, Ingham Analytics has a few to suggest in its latest research on how to 'politics-proof' your investment portfolio this Christmas. You can access the report here.

I hope you have a good weekend.

Stephen Gunnion

Managing Editor, InceConnect

 

 
Todays Latest Headlines
 
Prosus bruised in Just Eat food fight
Prosus bruised in Just Eat food fight
Just Eat continues to recommend that shareholders accept the Takeaway.com offer as it gains more acceptances.
SHARE THIS STORY Facebook        
 
   
 
Ascendis reports healthy Remedica sales
Ascendis reports healthy Remedica sales
Share in the pharmaceuticals group have tumbled further despite strong growth at Remedica, which has been marked for sale.
SHARE THIS STORY Facebook        
 
   
 
Weak trading weighs on JSE earnings
Weak trading weighs on JSE earnings
Once-off charges and a decline in trading activity will leave earnings up to 26 percent lower this year.
SHARE THIS STORY Facebook        
 
   
 
Glencore's Katanga buys land for tailings facility
Glencore's Katanga buys land for tailings facility
The land will help Kamoto Copper Company operate its mines, facilities and infrastructure more efficiently.
SHARE THIS STORY Facebook        
 
   
 
PSG sells Alaris stake to Tadvest
PSG sells Alaris stake to Tadvest
The investment group says the disposal is in line with its strategy to focus on core investments and to hold controlling interests.
SHARE THIS STORY Facebook        
 
   
     
  Facebook     Twitter     LinedIn     Ince Connect      
     
     
  This email was sent to newsletter@newslettercollector.com on 2019-12-23  
 
INCE - A trusted brand in investor
communications for almost 100 years.
 
  SUBSCRIBE   |   UNSUBSCRIBE   
     
 
Powered by Ince (Pty) Ltd | 42 Wierda Rd W, Wierda Valley | Sandton | Gauteng | 2196 | South Africa